| |
| |
|
| Insider
Information: |
Low Philip S |
| Relationship: |
Director |
| City: |
West Lafayette |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
455,309 |
|
|
Indirect Shares
|
63,974 |
|
|
| Direct
Value |
$437,097 |
|
|
|
Indirect Value
|
$61,415 |
|
|
| Total
Shares |
519,283 |
|
|
| Total
Value |
$498,512 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Endocyte Inc |
ECYT |
Chief Science Officer... |
2018-12-21 |
0 |
2018-12-21 |
0 |
Premium* |
|
|
Cortexyme, Inc. |
CRTX |
Director |
2022-05-19 |
455,309 |
2022-05-19 |
63,974 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
47 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ECYT |
Endocyte Inc |
Chief Science OfficerOfficer |
• • – |
2011-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
431,597 |
|
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2012-01-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
15,000 |
419,117 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2013-07-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
191,798 |
191,798 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
205,819 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2014-03-13 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,520 |
199,299 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2014-03-13 |
4 |
GA |
$0.00 |
$0 |
I/I |
1,520 |
193,318 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2014-12-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,484 |
188,815 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2015-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
197,565 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
219,948 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2016-05-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,566 |
206,606 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2017-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
17,500 |
251,187 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2017-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
288,605 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2017-11-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,600 |
283,005 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2017-12-22 |
4 |
GD |
$0.00 |
$0 |
I/I |
8,333 |
184,985 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
326,039 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2018-09-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
294 |
325,745 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2018-09-07 |
4/A |
GD |
$0.00 |
$0 |
D/D |
294 |
327,478 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2018-12-12 |
4 |
GD |
$0.00 |
$0 |
I/I |
52,512 |
132,473 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2018-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
52,346 |
269,204 |
0 |
- |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
I/I |
63,974 |
63,974 |
0 |
- |
|
| CRTX |
Cortexyme, Inc. |
Director |
– • – |
2022-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
455,309 |
455,309 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2015-02-10 |
4 |
OE |
$1.91 |
$1,039 |
D/D |
544 |
198,109 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2017-02-06 |
4 |
D |
$2.18 |
$1,513 |
D/D |
(694) |
248,605 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2013-09-24 |
4 |
OE |
$1.91 |
$1,910 |
D/D |
1,000 |
194,319 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Science Officer |
• • – |
2013-10-15 |
4 |
OE |
$1.91 |
$1,910 |
D/D |
1,000 |
195,319 |
0 |
- |
|
47 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
